Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.
Álvarez G, Martínez J, Varela J, Birriel E, Cruces E, Gabay M, Leal SM, Escobar P, Aguirre-López B, Cabrera N, Tuena de Gómez-Puyou M, Gómez Puyou A, Pérez-Montfort R, Yaluff G, Torres S, Serna E, Vera de Bilbao N, González M, Cerecetto H. Álvarez G, et al. Among authors: yaluff g. Eur J Med Chem. 2015 Jul 15;100:246-56. doi: 10.1016/j.ejmech.2015.06.018. Epub 2015 Jun 12. Eur J Med Chem. 2015. PMID: 26094151
Indazole N-oxide derivatives as antiprotozoal agents: synthesis, biological evaluation and mechanism of action studies.
Gerpe A, Aguirre G, Boiani L, Cerecetto H, González M, Olea-Azar C, Rigol C, Maya JD, Morello A, Piro OE, Arán VJ, Azqueta A, de Ceráin AL, Monge A, Rojas MA, Yaluff G. Gerpe A, et al. Among authors: yaluff g. Bioorg Med Chem. 2006 May 15;14(10):3467-80. doi: 10.1016/j.bmc.2006.01.007. Epub 2006 Feb 17. Bioorg Med Chem. 2006. PMID: 16483783
Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studies.
Roldos V, Nakayama H, Rolón M, Montero-Torres A, Trucco F, Torres S, Vega C, Marrero-Ponce Y, Heguaburu V, Yaluff G, Gómez-Barrio A, Sanabria L, Ferreira ME, Rojas de Arias A, Pandolfi E. Roldos V, et al. Among authors: yaluff g. Eur J Med Chem. 2008 Sep;43(9):1797-807. doi: 10.1016/j.ejmech.2007.11.007. Epub 2007 Nov 19. Eur J Med Chem. 2008. PMID: 18192088
In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles.
Boiani L, Gerpe A, Arán VJ, Torres de Ortiz S, Serna E, Vera de Bilbao N, Sanabria L, Yaluff G, Nakayama H, Rojas de Arias A, Maya JD, Morello JA, Cerecetto H, González M. Boiani L, et al. Among authors: yaluff g. Eur J Med Chem. 2009 Mar;44(3):1034-40. doi: 10.1016/j.ejmech.2008.06.024. Epub 2008 Jun 28. Eur J Med Chem. 2009. PMID: 18706738
3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies.
Benitez D, Cabrera M, Hernández P, Boiani L, Lavaggi ML, Di Maio R, Yaluff G, Serna E, Torres S, Ferreira ME, Vera de Bilbao N, Torres E, Pérez-Silanes S, Solano B, Moreno E, Aldana I, López de Ceráin A, Cerecetto H, González M, Monge A. Benitez D, et al. Among authors: yaluff g. J Med Chem. 2011 May 26;54(10):3624-36. doi: 10.1021/jm2002469. Epub 2011 May 4. J Med Chem. 2011. PMID: 21506600
Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in vivo activity.
Álvarez G, Varela J, Márquez P, Gabay M, Arias Rivas CE, Cuchilla K, Echeverría GA, Piro OE, Chorilli M, Leal SM, Escobar P, Serna E, Torres S, Yaluff G, Vera de Bilbao NI, González M, Cerecetto H. Álvarez G, et al. Among authors: yaluff g. J Med Chem. 2014 May 22;57(10):3984-99. doi: 10.1021/jm500018m. Epub 2014 May 2. J Med Chem. 2014. PMID: 24749923
34 results